Cargando…

S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria

S9.1 CHRONIC PULMONARY ASPERGILLOSIS - WHERE DO WE STAND?, SEPTEMBER 23, 2022, 4:45 PM - 6:15 PM: OBJECTIVES: Chronic pulmonary aspergillosis (CPA) is a known complication of post-TB treatment. It is a progressive disease characterized by progressive cavitation, fibrosis, and pleural thickening am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davies, Adeyinka, Adekoya, Abiola, Oladele, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511556/ http://dx.doi.org/10.1093/mmy/myac072.S9.1d

Ejemplares similares

Chronic cavitary pulmonary aspergillosis in an immunocompetent child
por: Davies, Adeyinka A., et al.
Publicado: (2022)

P388 High rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive
por: Setianingrum, Findra, et al.
Publicado: (2022)

P143 Incidence of chronic pulmonary aspergillosis in a cohort of bacteriologically confirmed TB patients at a tertiary hospital in Ghana
por: Ocansey, Bright, et al.
Publicado: (2022)

The diversity of latent TB
por: Young, Douglas
Publicado: (2010)

Assessment of TB underreporting by level of reporting system in Lagos, Nigeria
por: Gidado, M., et al.
Publicado: (2022)

Separating latent and acute TB
por: Doherty, T Mark
Publicado: (2010)

Genome-scale antibody responses in TB
por: Gennaro, Maria L
Publicado: (2010)

TB immunodiagnosis in context of global disease care and control
por: Perkins, Mark D
Publicado: (2010)

Systems approaches to uncovering in vivo state of the TB bacillus
por: McFadden, Johnjoe
Publicado: (2010)

HIV-TB the deadly duo, the biggest health challenge in Fiji
por: Muller, Santhakumari, et al.
Publicado: (2012)

Assessing new strategies for TB diagnosis in low- and middle-income countries
por: Kritski, Afranio Lineu, et al.
Publicado: (2014)

Tuberculosis in children perinatally exposed to HIV in the current epidemiological TB context
por: Vlad, Delia, et al.
Publicado: (2014)

9.1 Innate resistance of endothelial cells to the effects of glucocorticoids
por: Koenen, P, et al.
Publicado: (2008)

Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and population
por: Schechter, M
Publicado: (2010)

Profiling the immune response to TB infection on a genome-wide scale with protein microarrays
por: Felgner, Philip
Publicado: (2010)

The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB
por: Cadosch, Dominique, et al.
Publicado: (2016)

Influence of CD38/PD1 co-expression on T cell subsets in HIV-TB co-infection
por: Sunder, Sharada Ramaseri, et al.
Publicado: (2012)

P258 Incidence of Histoplasmosis, Cryptococcosis, and TB Among People Living with HIV in Paraguay-Preliminary Report
por: Samudio, Tania, et al.
Publicado: (2022)

Treatment and care of TB across Europe
por: Kirk, Ole
Publicado: (2014)

TB AND OTHER CHEST INFECTIONS
Publicado: (2022)

Quality of life among tuberculosis (TB), TB retreatment and/or TB-HIV co-infected primary public health care patients in three districts in South Africa
por: Louw, Julia, et al.
Publicado: (2012)

Risk Factor for Retreatment Episode on Admission Among TB Patients With Schizophrenia
por: Wang, Hai-Rong, et al.
Publicado: (2021)

Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
por: Adepoju, Victor Abiola, et al.
Publicado: (2023)

P408 Evaluation of fungal serum biomarkers in the diagnosis and for monitoring patients with post tuberculosis chronic pulmonary aspergillosis
por: Singh, Shreya, et al.
Publicado: (2022)

P203 Chronic pulmonary aspergillosis (CPA) in post tuberculosis sequele— aclinical experience from tertiary care
por: Gupta, Chhavi, et al.
Publicado: (2022)

Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB
por: Izudi, J., et al.
Publicado: (2022)

How Do Private Providers Unaffiliated With the Nigeria National TB Program Diagnose and Treat Drug-Susceptible TB Patients? A Cross-Sectional Study
por: Adepoju, Victor Abiola, et al.
Publicado: (2022)

Tuberculosis but not Immune Reconstitution Inflammatory Syndrome (IRIS) prevents early and late NK cell degranulation reconstitution in HIV/TB co-infected patients
por: Pean, Polidy, et al.
Publicado: (2011)

S10.4b Pathophysiology, diagnosis, and management of chronic pulmonary Aspergillosis
por: Izumikawa, Koichi
Publicado: (2022)

Management of drug-resistant TB in patients with HIV co-infection
por: Meintjes, Graeme
Publicado: (2014)

S2.2a African histoplasmosis
por: Oladele, Rita
Publicado: (2022)

TB AND OTHER CHEST INFECTIONS
Publicado: (2022)

16. TB or not TB? A mistaken case of SAPHO in a 65 year old male
por: Barton, Eleanor, et al.
Publicado: (2019)

P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022)

P459 The Aspergillus lateral flow assay for the diagnosis of chronic pulmonary aspergillosis
por: Peng, Jie, et al.
Publicado: (2022)

Patient Refusal of Glaucoma Surgery and Associated Factors in Lagos, Nigeria
por: Adekoya, Bola Josephine, et al.
Publicado: (2013)

P465 Aspergillosis in free-ranging Magellanic penguins
por: Trápaga, Mariana, et al.
Publicado: (2022)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles
por: Fakhim, Hamed, et al.
Publicado: (2022)

P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis
por: Perales-Martinez, Diana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97ge8dqvdodlj2fbpa7cjg133q